Methods and means for soft tissue engineering
View Patent ↗Cellfree adipose tissue extracts, implants including the same and methods for the preparation thereof. The extracts and implants are capable of inducing adipogenesis and angiogenesis and are, thus, useful in applications including soft tissue repair and engineering and angiogenesis induction, e.g., in wound healing, treatment of burn injuries and ischemic conditions.
1. A cellfree adipose tissue extract, comprising: VEGF, FGF-2, and IGF-1 of small adipose tissue pieces containing viable cells, wherein a ratio of IGF-1 to FGF-2 is between 2:1 to 1:2, and a ratio of VEGF to FGF-2 is between 1:100 to 1:10, and wherein the cellfree adipose tissue extract is obtained without cell culturing.
2. The extract according to claim 1 , wherein the growth factor content per 1 mg of total protein is at least 1 pg of VEGF, at least 70 pg of FGF-2, and at least 50 pg of IGF-1.
3. The extract according to claim 2 , wherein the VEGF content per 1 mg of total protein is at least 7 pg.
4. The extract according to claim 2 , further comprising angiogenin, adiponectin, TIMP-1 and TIMP-2, MIF, IGFBP-6, NAP-2, leptin, PDGF-BB and GRO.
5. The extract according to claim 2 , further comprising angiogenin, IL-5, IL-6, IL-8, CCL5, NAP-2, MCP-1, adiponectin, GRO, TIMP-1, and TIMP-2.
6. The extract according to claim 1 , the extract adapted for use in soft tissue repair or engineering, in wound healing, in treating burn injuries or in treating ischemic conditions.
7. The extract according to claim 2 , the extract adapted for use in soft tissue repair or engineering, in wound healing, in treating burn injuries or in treating ischemic conditions.
8. An implant comprising a cellfree adipose tissue extract according to claim 1 and a biocompatible matrix.
9. An implant comprising a cellfree adipose tissue extract according to claim 2 and a biocompatible matrix.
10. The implant according to claim 8 , wherein the biocompatible matrix is a hydrogel.
11. The implant according to claim 10 , wherein the hydrogel is selected from a group consisting of hyaluronic acid, chitosan, fibrin, collagen, alginate, polyesters based on poly lactic acid, poly lactic glycolic acid, polycaprolactone, and mixtures thereof.
12. The implant according to claim 8 , which is injectable.
13. The implant according to claim 8 , wherein the extract is allogenic.
14. The implant according to claim 8 , the implant adapted for use in soft tissue repair or engineering, in wound healing, in treating burn injuries or in treating ischemic conditions.
15. A method of preparing the cellfree adipose tissue extract according to claim 1 comprising a predetermined amount of VEGF, FGF-2, and IGF-1, the method comprising the following steps:
a) providing a non-homogenized adipose tissue sample comprising viable cells,
b) incubating the sample a predetermined time, and
c) collecting the extract the method excluding a step of cell culturing.
16. The method of claim 15 , wherein the growth factor content per 1 mg of total protein is at least 1 pg of VEGF, at least 70 pg of FGF-2, and at least 50 pg of IGF-1.
17. A cellfree adipose tissue extract obtained by the method according to claim 15 .
18. A method of preparing an implant according to claim 8 , the method comprising mixing the adipose tissue extract with, or absorbing the same into, the biocompatible material.
19. A method of inducing adipogenesis, the method comprising implanting into a subject in need thereof an implant according to claim 8 .
20. A method of inducing angiogenesis, the method comprising implanting into a subject in need thereof an implant according to claim 8 .